NHS secures access to BNF content for next 12 years
National Institute for Health and Care Excellence (NICE) has granted a 12-year contract to the NHS to access the British National Formulary (BNF) content.
BNF for...
Pharmacy funding for 2021/22 remains unchanged at £2.59bn; stakeholders disappointed
The government has kept funding for the Community Pharmacy Contractual Framework (CPCF) unchanged at £2.592 billion for the year 2021/22, keeping the allocation same...
RB Healthcare buys 11 new pharmacies with £12.5m funding from Santander
Merseyside-based independent community pharmacy group RB Healthcare has entered a deal to buy 11 more sites in Manchester and Merseyside after receiving a £12.5...
NICE draft guidance extends recommendation for sapropterin to pregnant women
NICE has issued final draft guidance recommending sapropterin (also called Kuvan and made by BioMarin) as an option to treat phenylketonuria (PKU) in pregnant...
Better Care Fund increased to support health and care integration
The Better Care Fund (BCF) will be a minimum of £6.9 billion in 2021 to 2022, including £4.3 billion of NHS funding and £2.1...
National Covid-19 antibody surveillance programme launched
A national Covid-19 antibody surveillance programme has been launched by the UK Health Security Agency to collect data to build the government’s understanding of...
August 2021 price concessions announced
The Department of Health and Social Care (DHSC) has granted the following price concessions for August 2021:
Drug
Pack size
Price Concession
Etoricoxib 90mg tablets
28
£7.29
Ivabradine 5mg tablets
56
£12.19
Ivabradine 7.5mg...
UK orders 35m more Pfizer/BioNTech Covid jabs
Britain has ordered 35 million more doses of the Pfizer/BioNTech Covid-19 vaccine to prepare for booster shots and to counter any new variants.
"While we continue to...
Contractor Case Study: Implementing GP CPCS benefits patients
Inclusion of referrals from general practices into the Community Pharmacist Consultation Service (CPCS) has benefited several patients, who could avail a face to face...
AstraZeneca hails Covid treatment trial results
Drug firm AstraZeneca on Friday announced positive results from a trial of a treatment for Covid-19 symptoms.
The drug, made from a combination of two...
Current Issue March 2024
